Skip to main content
Erschienen in: Journal of Genetic Counseling 5/2017

16.03.2017 | Original Research

Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome

verfasst von: Melissa A. Alderfer, Robert B. Lindell, Claire I. Viadro, Kristin Zelley, Jessica Valdez, Belinda Mandrell, Carol A. Ford, Kim E. Nichols

Erschienen in: Journal of Genetic Counseling | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Whether children should be offered genetic testing for cancer risk is much debated but young voices are rarely heard in these conversations. The current study explored perspectives of genetic testing held by adolescents and emerging adults in families with Li Fraumeni syndrome (LFS). Twelve 12- to 25-year-olds in families with LFS completed qualitative interviews for this study. All believed that testing should be offered for children but many qualified this statement saying parental approval would be needed and testing should be optional. Genetic testing was seen as way to learn of risk status, allow for disease prevention efforts, and reduce uncertainty and anxiety. Perceived disadvantages included negative emotions associated with the testing result. Participants generally felt that children should be involved in the testing decision, but that parents could unilaterally decide to have a child tested in certain circumstances (e.g., young age, high risk). All who were aware of having been tested and of their test result (n = 7; 4 positive) said testing had no negative impact on their outlook and they agreed with the decision to undergo testing. Implications of these findings for clinical practice and future research are discussed.
Fußnoten
1
A total of 25 families from the parent study had adolescents/emerging adults in the 12 to 25-year-old age range and 17 families (68%) agreed to participate. Across the 17 participating families, 45 adolescents/emerging adults fell in our target age range and 30 (67%) completed interviews. This report focuses on a subset of this larger sample; specifically 12 adolescents/emerging adults in families with LFS.
 
Literatur
Zurück zum Zitat Alderfer, M. A., Zelley, K., Lindell, R. B., Novokmet, A., Mai, P. L., et al. (2015). Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer, 121, 286–293. doi:10.1002/cncr.29027.CrossRefPubMed Alderfer, M. A., Zelley, K., Lindell, R. B., Novokmet, A., Mai, P. L., et al. (2015). Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer, 121, 286–293. doi:10.​1002/​cncr.​29027.CrossRefPubMed
Zurück zum Zitat Bradbury, A. R., Patrick-Miller, L., Pawlowski, K., Ibe, C. N., Cummings, S. A., et al. (2008). Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring. American Journal of Medical Genetics Part C Seminars in Medical Genetics, 148C, 70–77. doi:10.1002/ajmg.c.30163.CrossRef Bradbury, A. R., Patrick-Miller, L., Pawlowski, K., Ibe, C. N., Cummings, S. A., et al. (2008). Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring. American Journal of Medical Genetics Part C Seminars in Medical Genetics, 148C, 70–77. doi:10.​1002/​ajmg.​c.​30163.CrossRef
Zurück zum Zitat Bradbury, A. R., Patrick-Miller, L., Pawlowski, K., Ibe, C. N., Cummings, S. A., et al. (2009). Learning of your parent’s BRCA mutation during adolescence or early adulthood: A study of offspring experiences. Psycho-Oncology, 18, 200–208. doi:10.1002/pon.1384.CrossRefPubMedPubMedCentral Bradbury, A. R., Patrick-Miller, L., Pawlowski, K., Ibe, C. N., Cummings, S. A., et al. (2009). Learning of your parent’s BRCA mutation during adolescence or early adulthood: A study of offspring experiences. Psycho-Oncology, 18, 200–208. doi:10.​1002/​pon.​1384.CrossRefPubMedPubMedCentral
Zurück zum Zitat Bradbury, A. R., Patrick-Miller, L., Egleston, B. L., Schwartz, L. A., Sands, C. B., et al. (2012). Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Research and Treatment, 136, 749–757. doi:10.1007/s10549-012-2254-7.CrossRefPubMedPubMedCentral Bradbury, A. R., Patrick-Miller, L., Egleston, B. L., Schwartz, L. A., Sands, C. B., et al. (2012). Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Research and Treatment, 136, 749–757. doi:10.​1007/​s10549-012-2254-7.CrossRefPubMedPubMedCentral
Zurück zum Zitat Codori, A.-M., Zawacki, K. L., Petersen, G. M., Miglioretti, D. L., Bacon, J. A., et al. (2003). Genetic testing for hereditary colorectal cancer in children: Long-term psychological effects. American Journal of Medical Genetics, 116A, 117–128. doi:10.1002/ajmg.a.10926.CrossRefPubMed Codori, A.-M., Zawacki, K. L., Petersen, G. M., Miglioretti, D. L., Bacon, J. A., et al. (2003). Genetic testing for hereditary colorectal cancer in children: Long-term psychological effects. American Journal of Medical Genetics, 116A, 117–128. doi:10.​1002/​ajmg.​a.​10926.CrossRefPubMed
Zurück zum Zitat Daly, M.B., Axilbund, J.E., Bryant, E., Buys, S., Eng, C., et al. (2006). Genetic/familial high-risk assessment: Breast and ovarian. Journal of the National Comprehensive Cancer Network, 4, 156–176. PMID: 6451772 Daly, M.B., Axilbund, J.E., Bryant, E., Buys, S., Eng, C., et al. (2006). Genetic/familial high-risk assessment: Breast and ovarian. Journal of the National Comprehensive Cancer Network, 4, 156–176. PMID: 6451772
Zurück zum Zitat Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2008). “You’re one of us now”: Young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics Part C (Seminars in Medical Genetics), 148C, 47–55. doi:10.1002/ajmg.c.30158.CrossRef Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2008). “You’re one of us now”: Young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics Part C (Seminars in Medical Genetics), 148C, 47–55. doi:10.​1002/​ajmg.​c.​30158.CrossRef
Zurück zum Zitat Fanos, J. H. (1997). Developmental tasks of childhood and adolescence: Implications for genetic testing. American Journal of Medical Genetics, 71, 22–28.CrossRefPubMed Fanos, J. H. (1997). Developmental tasks of childhood and adolescence: Implications for genetic testing. American Journal of Medical Genetics, 71, 22–28.CrossRefPubMed
Zurück zum Zitat Hamann, H., Croyle, R. T., Venne, V. L., Baty, B. J., Smith, K. R., & Botkin, J. R. (2000). Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation. American Journal of Medical Genetics, 92, 25–32.CrossRefPubMed Hamann, H., Croyle, R. T., Venne, V. L., Baty, B. J., Smith, K. R., & Botkin, J. R. (2000). Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation. American Journal of Medical Genetics, 92, 25–32.CrossRefPubMed
Zurück zum Zitat Kamihara, J., Rana, H. Q., & Garber, J. E. (2014). Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Human Mutation, 35, 654–662.CrossRefPubMed Kamihara, J., Rana, H. Q., & Garber, J. E. (2014). Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Human Mutation, 35, 654–662.CrossRefPubMed
Zurück zum Zitat Kesserwan, C., Ross, L. F., Bradbury, A. R., & Nichols, K. E. (2016). The advantages and challenges of testing children for heritable predisposition to cancer. American Society of Clinical Oncology Educational Book, 35, 251–269. doi:10.14694/EDBK_160621.CrossRefPubMed Kesserwan, C., Ross, L. F., Bradbury, A. R., & Nichols, K. E. (2016). The advantages and challenges of testing children for heritable predisposition to cancer. American Society of Clinical Oncology Educational Book, 35, 251–269. doi:10.​14694/​EDBK_​160621.CrossRefPubMed
Zurück zum Zitat Masciari, S., Van den Abbeele, A. D., Diller, L. R., Rastarhuyeva, I., Yap, J., et al. (2008). F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA, 299, 1315–1319. doi:10.1001/jama.299.11.1315.CrossRefPubMed Masciari, S., Van den Abbeele, A. D., Diller, L. R., Rastarhuyeva, I., Yap, J., et al. (2008). F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA, 299, 1315–1319. doi:10.​1001/​jama.​299.​11.​1315.CrossRefPubMed
Zurück zum Zitat Oppenheim, D., Brugieres, L., Chompret, A., & Hartmann, O. (2001). The psychological burden inflicted by multiple cancers in Li Fraumeni syndrome: Five case studies. Journal of Genetic Counseling, 10, 169–183.CrossRef Oppenheim, D., Brugieres, L., Chompret, A., & Hartmann, O. (2001). The psychological burden inflicted by multiple cancers in Li Fraumeni syndrome: Five case studies. Journal of Genetic Counseling, 10, 169–183.CrossRef
Zurück zum Zitat Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013). Technical report: Ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15, 234–245. doi:10.1038/gim.2012.176.CrossRefPubMed Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013). Technical report: Ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15, 234–245. doi:10.​1038/​gim.​2012.​176.CrossRefPubMed
Zurück zum Zitat Schreier, M. (2012). Qualitative content analysis in practice. Thousand Oaks: Sage. Schreier, M. (2012). Qualitative content analysis in practice. Thousand Oaks: Sage.
Zurück zum Zitat Villani, A., Tabori, U., Schiffman, J., Shlien, A., Beyene, J., et al. (2011). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncology, 12, 559–567. doi:10.1016/S1470-2045(11)70119-X.CrossRefPubMed Villani, A., Tabori, U., Schiffman, J., Shlien, A., Beyene, J., et al. (2011). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncology, 12, 559–567. doi:10.​1016/​S1470-2045(11)70119-X.CrossRefPubMed
Zurück zum Zitat Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., et al. (2016). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11-year follow-up of a prospective observational study. Lancet Oncology, 17, 1295–1305. doi:10.1016/S1470-2045(16)30249-2.CrossRefPubMed Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., et al. (2016). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11-year follow-up of a prospective observational study. Lancet Oncology, 17, 1295–1305. doi:10.​1016/​S1470-2045(16)30249-2.CrossRefPubMed
Metadaten
Titel
Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome
verfasst von
Melissa A. Alderfer
Robert B. Lindell
Claire I. Viadro
Kristin Zelley
Jessica Valdez
Belinda Mandrell
Carol A. Ford
Kim E. Nichols
Publikationsdatum
16.03.2017
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 5/2017
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-017-0091-x

Weitere Artikel der Ausgabe 5/2017

Journal of Genetic Counseling 5/2017 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.